Key result
Routine DOAC use in ischemic stroke patients is linked to uncommon symptomatic intracranial hemorrhage.
Should not yet change DOAC use post-stroke; leaves open causal effects pending better-controlled studies.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Purrucker et al. (2026) conducted a letter in Ischemic stroke. Direct oral anticoagulants (DOACs) vs. No anticoagulation was evaluated on Symptomatic intracranial hemorrhage. Symptomatic intracranial hemorrhage was uncommon in routine care among ischemic stroke patients on DOACs, though baseline imbalances limit causal interpretation.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: